DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Chapple CR, Rechberger T, Al-Shukri S , et al; YM-905 Study Group.
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
BJU Int 2004;
93 (3) 303-310
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.